Oxfordbiotherapeutics
The Preclinical Program Coordinator supports the Program Office in delivering OBT’s preclinical programs by maintaining high-quality documentation, ensuring compliance, and assisting with audits and coordination activities. The role provides operational and administrative support to Program Managers and scientific teams, facilitating information flow, document control, and meeting preparation across preclinical projects.
Headquarters
Oxford, England, United Kingdom
Company Size
11-50 employees
Founded
2004
Oxford BioTherapeutics is a biotechnology company focused on developing first‑in‑class oncology therapies. They pioneer targeted approaches including Antibody‑Drug Conjugates (ADCs), immuno‑oncology agents, T‑Cell Engagers (TCEs), and radiopharmaceuticals. The company advances a pipeline driven by translational science and strategic partnerships to accelerate delivery of novel cancer treatments to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Oxfordbiotherapeutics.
21% above the average for this role